US4946684A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Fast dissolving dosage forms
Assignee: Wyeth LLC
•
Filing: 1989-06-20
•
Granted: 1990-08-07
•
Expires: 2009-06-20
Abstract
Abstract A pharmaceutical dosage form is provided which disintegrates rapidly in water having an open matrix network structure comprised of mannitol and a natural gum and which can be used particularly for oral administration to pediatric and geriatric patients.
Inventors
- 👤 Robert G. Blank
- 👤 Dhiraj S. Mody
- 👤 Richard J. Kenny
- 👤 Martha C. Aveson
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 23:44
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/20; A61K9/2004; A61K9/2022; A61K9/205; A61K9/2013; A61K9/2018; A61K9/2095
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
99 words
In a pharmaceutical dosage form for oral administration as a solid, whicih dosage form can be disintegrated by water within ten seconds and which consists essentially of an open matrix network carrying a unit dosage of a water soluble pharmaceutical substance, the open matric network consisting essentially of a pharmacologically accceptable water-soluble or water-dispersible carrier material, the improvement which comprises selecting the carrier material from the group consisting essentially of mannitol in admixture with at least one natural gum, the mannitol content of the solid dosage form constituting at least abouty 50% by weight of the solid dosage form.
Claim 2
Dependent Claim
99 words
In a pharmaceutical dosage form for oral administration as a solid, whicih dosage form can be disintegrated by water within ten seconds and which consists essentially of an open matrix network carrying a unit dosage of a water soluble pharmaceutical substance, the open matric network consisting essentially of a pharmacologically accceptable water-soluble or water-dispersible carrier material, the improvement which comprises selecting the carrier material from the group consisting essentially of mannitol in admixture with at least one natural gum, the mannitol content of the solid dosage form constituting at least abouty 50% by weight of the solid dosage form.
Claim 3
Dependent Claim
27 words
The pharmaceutical dosage from of claim 1 wherein the natural gum is selected from the group consisting of acacia gum, guar gum, xanthan gum and tragacanth gum.
Claim 4
Dependent Claim
23 words
The pharmaceutical dosage form of claim 2 wherein the natural gum content of the solid dosage form is about 0.07% to 3.2% weight.
References Cited (Backward Citations)
US4371516A
Cited
US4698264A
Cited
US4695463A
Cited
US4803081A
Cited
US4760093A
Cited
US4760094A
Cited
US4767789A
Cited
US4771077A
Cited
US4835186A
Cited
US4835187A
Cited
US4835188A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1993-08-06 | 1994-02-05 | 1994-08-07 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1997-08-06 | 1998-02-05 | 1998-08-07 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2001-08-06 | 2002-02-05 | 2002-08-07 | $7700.00 | Window Closed / Lapsed |